Bi Asset Management Fondsmaeglerselskab A Biomarin Pharmaceutical Inc Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $9.48 Billion
- Q4 2024
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 28,061 shares of BMRN stock, worth $1.84 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,061
Previous 26,357
6.47%
Holding current value
$1.84 Million
Previous $1.85 Million
0.49%
% of portfolio
0.02%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.27 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.19 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$968 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$852 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...